IP Library › Granted Patent US 12,276,053
Granted Patent B2
US 12,276,053 · App. 18/529,513 · Granted Apr 15, 2025

Atraumatic stent and method and apparatus for making the same

Inventors: Steve Lilburn (Princeton, MA); Paul K. Norton (Lunenburg, MA); Michael E. Zupkofska (Rockland, MA); Louis Bedard (Leominster, MA); Glenn Harding (Sutton, MA)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
D04C3/48A61F2/82A61F2/90D04C1/06D04C3/14A61F2002/91508A61F2002/91516A61F2002/91525A61F2230/0069A61F2240/00A61F2250/0018D04C1/02D10B2509/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,276,053
App. No.
18/529,513
Granted
Apr 15, 2025
Kind
B2
Abstract

A method of braiding a stent includes braiding a number of elongate filaments around a mandrel using tensioned braiding carriers without spooling the filaments to the tensioned braiding carriers to form a braided stent having atraumatic ends.

Claims (27)

1. A method of making a stent comprising:

securing an intermediate portion of each of a plurality of filaments around a respective securement projection at a first end region of a mandrel; and

braiding the plurality of filaments along a cylindrical body of the mandrel toward a second end of the mandrel, wherein the mandrel includes a plurality of helical grooves defined between adjacent raised projections positioned along the cylindrical body of the mandrel, wherein braiding includes disposing the plurality of filaments into the plurality of grooves.

2. The method of claim 1 , further comprising:

forming closed loops with the filaments at the second end of the mandrel, the closed loops defining an end of the stent.

3. The method of claim 2 , wherein the closed loops are formed by bending the filaments around projections at the second end of the mandrel.

4. The method of claim 1 , wherein the first end region of the mandrel has a larger diameter than the cylindrical body of the mandrel.

5. The method of claim 1 , wherein the raised projections along the cylindrical body have a pyramid shape with a truncated and/or rounded top portion.

6. The method of claim 5 , wherein the braiding step includes guiding the filaments into the grooves with the raised projections.

7. The method of claim 1 , wherein braiding includes forming the stent with a flared region at a first end of the stent, the flared region having a larger diameter than a body of the stent.

8. The method of claim 7 , wherein the flared region is formed around the first end region of the mandrel and the body of the stent is formed around the cylindrical body of the mandrel.

9. The method of claim 8 , wherein a braiding angle between intersecting braided filaments along the body of the stent is substantially equal to a braiding angle between intersecting braided filaments along the flared region.

10. The method of claim 9 , wherein the braiding angle is 110 degrees+/−3 degrees in both the flared region and the body of the stent.

11. The method of claim 9 , wherein a braiding angle between intersecting braided filaments along a transition region of the stent is substantially equal to the braiding angle between intersecting braided filaments along the body of the stent and the braiding angle between intersecting braided filaments along the flared region, the transition region extending between the flared region and the body of the stent.

12. The method of claim 11 , wherein the braiding angle is 110 degrees+/−3 degrees in each of the flared region, the body, and the transition region of the stent.

13. The method of claim 1 , wherein braiding is achieved by moving a plurality of constant force braiding carriers in a circular and serpentine motion as the mandrel is longitudinally advanced.

14. A method of making a stent comprising:

securing an intermediate portion of each of a plurality of filaments around a respective securement projection at a first end region of a mandrel, the intermediate portions of the filaments defining a first end of the stent;

braiding the plurality of filaments along a cylindrical body of the mandrel toward a second end of the mandrel, wherein the mandrel includes a plurality of helical grooves defined between adjacent raised projections positioned along the cylindrical body of the mandrel, wherein braiding includes disposing the plurality of filaments into the plurality of grooves; and

forming closed loops with the filaments at the second end of the mandrel, the closed loops defining second end of the stent;

wherein the stent includes a flared region at the first end of the stent, the flared region having a larger diameter than a body of the stent.

15. The method of claim 14 , wherein the closed loops are formed by bending the filaments around projections at the second end of the mandrel.

16. The method of claim 14 , wherein the raised projections along the cylindrical body have a pyramid shape with a truncated and/or rounded top portion.

17. The method of claim 16 , wherein the braiding step includes guiding the filaments into the grooves with the raised projections.

18. The method of claim 14 , wherein a braiding angle between intersecting braided filaments along the body of the stent is substantially equal to a braiding angle between intersecting braided filaments along the flared region.

19. The method of claim 18 , wherein a braiding angle between intersecting braided filaments along a transition region of the stent is substantially equal to the braiding angle between intersecting braided filaments along the body of the stent and the braiding angle between intersecting braided filaments along the flared region, the transition region extending between the flared region and the body of the stent.

20. The method of claim 19 , wherein the braiding angle is 110 degrees+/−3 degrees in each of the flared region, the body, and the transition region of the stent.

Continuity (10)
Continuation 18158821 · Jan 24, 2023
Continuation 17181474 · Feb 22, 2021
Continuation 16364772 · Mar 26, 2019
Continuation 15204508 · Jul 7, 2016
Continuation 14096307 · Dec 4, 2013
Continuation 13912445 · Jun 7, 2013
Continuation 13441649 · Apr 6, 2012
Continuation 12630068 · Dec 3, 2009
Provisional Application 61147307 · Jan 26, 2009
Related Publication 20240125020A1 · Apr 18, 2024
References Cited (98)
US 1945195A · Kellems · 1934 [cited by applicant]
US 2230723A · Maclachlan · 1941 [cited by applicant]
US 2557816A · Di Palma · 1951 [cited by applicant]
US 3881522A · Lewis et al. · 1975 [cited by applicant]
US 4130046A · Sokol · 1978 [cited by applicant]
US 4202718A · Mizutani et al. · 1980 [cited by applicant]
US 4519290A · Inman et al. · 1985 [cited by applicant]
US 4655771A · Wallsten · 1987 [cited by applicant]
US 4893543A · Phillips · 1990 [cited by applicant]
US 5037404A · Gold et al. · 1991 [cited by applicant]
US 5127919A · Ibrahim et al. · 1992 [cited by applicant]
US 5405377A · Cragg · 1995 [cited by applicant]
US 5476027A · Uchida et al. · 1995 [cited by applicant]
US 5501133A · Brookstein et al. · 1996 [cited by applicant]
US 5575818A · Pinchuk · 1996 [cited by applicant]
US 5591226A · Trerotola et al. · 1997 [cited by applicant]
US 5645559A · Hachtman et al. · 1997 [cited by applicant]
US 5800519A · Sandock · 1998 [cited by applicant]
US 5824077A · Mayer · 1998 [cited by applicant]
US 5849037A · Frid · 1998 [cited by applicant]
US 5906641A · Thompson et al. · 1999 [cited by applicant]
US 6071308A · Ballou et al. · 2000 [cited by applicant]
US 6241757B1 · An et al. · 2001 [cited by applicant]
US 6508276B2 · Radlinger et al. · 2003 [cited by applicant]
US 6520983B1 · Colgan et al. · 2003 [cited by applicant]
US 6585758B1 · Chouinard et al. · 2003 [cited by applicant]
US 6613078B1 · Barone · 2003 [cited by applicant]
US 6622604B1 · Chouinard et al. · 2003 [cited by applicant]
US 6626936B2 · Stinson · 2003 [cited by applicant]
US 6652571B1 · White et al. · 2003 [cited by applicant]
US 6792979B2 · Konya et al. · 2004 [cited by applicant]
US 6978643B2 · Akers et al. · 2005 [cited by applicant]
US 7001425B2 · McCullagh et al. · 2006 [cited by applicant]
US 7018401B1 · Hyodoh et al. · 2006 [cited by applicant]
US 7048014B2 · Hyodoh et al. · 2006 [cited by applicant]
US 7160323B2 · Pulnev et al. · 2007 [cited by applicant]
US 7311031B2 · McCullagh et al. · 2007 [cited by applicant]
US 8114147B2 · Wood et al. · 2012 [cited by applicant]
US 8151682B2 · Lilburn et al. · 2012 [cited by applicant]
US 8210084B2 · An · 2012 [cited by applicant]
US 8382825B2 · Garcia et al. · 2013 [cited by applicant]
US 8398701B2 · Berez et al. · 2013 [cited by applicant]
US 8459164B2 · Lilburn et al. · 2013 [cited by applicant]
US 8621975B2 · Russo et al. · 2014 [cited by applicant]
US 8677874B2 · Lilburn et al. · 2014 [cited by applicant]
US 9439790B2 · Clerc et al. · 2016 [cited by applicant]
US 9452070B2 · Kusleika · 2016 [cited by applicant]
US 10947651B2 · Lilburn · 2021 [cited by examiner]
US 11578437B2 · Lilburn · 2023 [cited by examiner]
US 20020035396A1 · Heath · 2002 [cited by applicant]
US 20020147489A1 · Hong et al. · 2002 [cited by applicant]
US 20030135265A1 · Stinson · 2003 [cited by applicant]
US 20030153973A1 · Soun et al. · 2003 [cited by applicant]
US 20040102855A1 · Shank · 2004 [cited by applicant]
US 20040133266A1 · Clerc et al. · 2004 [cited by applicant]
US 20040153117A1 · Clubb et al. · 2004 [cited by applicant]
US 20040193141A1 · Leopold et al. · 2004 [cited by applicant]
US 20050049682A1 · Leanna et al. · 2005 [cited by applicant]
US 20050256563A1 · Clerc et al. · 2005 [cited by applicant]
US 20050283962A1 · Boudjemline · 2005 [cited by applicant]
US 20060116752A1 · Norton et al. · 2006 [cited by applicant]
US 20060136043A1 · Cully et al. · 2006 [cited by applicant]
US 20060184238A1 · Kaufmann et al. · 2006 [cited by applicant]
US 20070078512A1 · Sowinski et al. · 2007 [cited by applicant]
US 20070119295A1 · McCullagh et al. · 2007 [cited by applicant]
US 20070168018A1 · Amplatz et al. · 2007 [cited by applicant]
US 20070270932A1 · Headley et al. · 2007 [cited by applicant]
US 20070293927A1 · Frank et al. · 2007 [cited by applicant]
US 20080167709A1 · An · 2008 [cited by applicant]
US 20080183272A1 · Wood et al. · 2008 [cited by applicant]
US 20090157158A1 · Ondracek et al. · 2009 [cited by applicant]
US 20090177268A1 · Lundkvist et al. · 2009 [cited by applicant]
US 20090187240A1 · Clerc et al. · 2009 [cited by applicant]
US 20090198315A1 · Boudjemline · 2009 [cited by applicant]
US 20090312834A1 · Wood et al. · 2009 [cited by applicant]
US 20100191319A1 · Lilburn et al. · 2010 [cited by applicant]
US 20110265908A1 · Clerc et al. · 2011 [cited by applicant]
US 20120150277A1 · Wood et al. · 2012 [cited by applicant]
US 20120186420A1 · Lilburn et al. · 2012 [cited by applicant]
US 20130090720A1 · Mahr et al. · 2013 [cited by applicant]
US 20130184808A1 · Hall et al. · 2013 [cited by applicant]
US 20130268063A1 · Firstenberg et al. · 2013 [cited by applicant]
US 20140277573A1 · Gill et al. · 2014 [cited by applicant]
US 20150051693A1 · Bertolino et al. · 2015 [cited by applicant]
US 20150134074A1 · Walsh et al. · 2015 [cited by applicant]
US 20170333230A1 · Folan et al. · 2017 [cited by applicant]
US 20180263797A1 · Eller et al. · 2018 [cited by applicant]
EP 150566A2 · 1985 [cited by applicant]
EP 423916A1 · 1991 [cited by applicant]
EP 775471B1 · 2002 [cited by applicant]
FR 2847155A1 · 2004 [cited by applicant]
JP 2002535075A · 2002 [cited by applicant]
JP 2004519307A · 2004 [cited by applicant]
JP 2006506201A · 2006 [cited by applicant]
JP 2008067922A · 2008 [cited by applicant]
WO 0061464A1 · 2000 [cited by applicant]
WO 02081019A1 · 2002 [cited by applicant]
International Search Report and Written Opinion dated Aug. 16, 2012, for International Application No. PCT/US2010/022082. [cited by applicant]